[조사 보고서] 세계의 윌슨병 치료제 시장 2023-2027

■ 영문 제목 : Global Wilson's Disease Drugs Market 2023-2027
	■ 상품코드 : IRTNTR75840-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 7월 ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문후 24시간내) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD2,500 ⇒환산￦3,375,000	견적의뢰/주문/질문
Enterprise License (기업 열람용)	USD4,000 ⇒환산￦5,400,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 윌슨병 치료제 시장 2023-2027
윌슨병 치료제 시장은 2022년에서 2027년까지 1억 7,997만 달러로 성장하며, 예측 기간 동안 6.32%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 윌슨병 치료제 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장 원동력은 질병 치료에 대한 사람들의 인식 증가, 윌슨병 유병률 증가, 조기 진단의 보급률 증가입니다.

Technavio사의 윌슨병 치료제 시장은 다음과 같이 분류하고 있습니다.

제품별
- 킬레이트제
- 미네랄

유통 채널별
- 소매 약국
- 병원 약국
- 온라인 약국

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 보고서는 향후 몇 년 동안 윌슨병 치료제 시장의 성장을 촉진하는 주요 요인 중 하나로 만성 통증의 유병률 증가를 꼽고 있습니다. 또한, 환자 지원 프로그램의 도입 증가와 의약품 개발을 위한 R&D 활동의 발전은 시장의 큰 수요로 이어질 것으로 보입니다.

본 보고서는 윌슨병 치료제 시장에 대해 다음과 같은 영역을 다루고 있습니다.
- 윌슨병 치료제 시장 규모
- 윌슨병 치료제 시장 예측
- 윌슨병 치료제 시장의 산업 분석

이 보고서는 윌슨병 치료제 시장의 주요 업체인 ANI Pharmaceuticals Inc., Apotex Inc., AstraZeneca Plc, Bausch Health Co. Inc., Breckenridge Pharmaceutical Inc., Dr Reddys Laboratories Ltd., Endo International Plc, Lupin Ltd., Merck and Co. Inc., Navinta LLC, Noblepharma Co. Ltd., Panacea Biotec Ltd., Recordati S.p.A, Sanofi, Taj Pharmaceutical Ltd., Teva Pharmaceutical Industries Ltd., and Tsumura and Co. 등의 기업에 대해 분석하고 있습니다. 또한, 윌슨병 치료제 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것으로 예상되고 있습니다.

이 연구는 업계 주요 참여자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있는 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 벤더 선정 방법 및 분석을 제공합니다.

■ 보고서 개요

1. 개요
2. 세계의 윌슨병 치료제 시장 현황
3. 세계의 윌슨병 치료제 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 제품별 시장 분석
7. 유통 채널별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global wilsons disease drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global wilsons disease drugs market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Distribution Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Chelators – Market size and forecast 2022-2027
o Exhibit 34: Chart on Chelators – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Chelators – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Chelators – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Chelators – Year-over-year growth 2022-2027 (%)
o 6.4 Minerals – Market size and forecast 2022-2027
o Exhibit 38: Chart on Minerals – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Minerals – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Minerals – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Minerals – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
o Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Retail pharmacies – Market size and forecast 2022-2027
o Exhibit 48: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
o 7.4 Hospital pharmacies – Market size and forecast 2022-2027
o Exhibit 52: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
o 7.5 Online pharmacies – Market size and forecast 2022-2027
o Exhibit 56: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ million)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ million)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 ANI Pharmaceuticals Inc.
o Exhibit 111: ANI Pharmaceuticals Inc. – Overview
o Exhibit 112: ANI Pharmaceuticals Inc. – Product / Service
o Exhibit 113: ANI Pharmaceuticals Inc. – Key offerings
o 12.4 Apotex Inc.
o Exhibit 114: Apotex Inc. – Overview
o Exhibit 115: Apotex Inc. – Product / Service
o Exhibit 116: Apotex Inc. – Key offerings
o 12.5 AstraZeneca Plc
o Exhibit 117: AstraZeneca Plc – Overview
o Exhibit 118: AstraZeneca Plc – Product / Service
o Exhibit 119: AstraZeneca Plc – Key news
o Exhibit 120: AstraZeneca Plc – Key offerings
o 12.6 Bausch Health Co. Inc.
o Exhibit 121: Bausch Health Co. Inc. – Overview
o Exhibit 122: Bausch Health Co. Inc. – Business segments
o Exhibit 123: Bausch Health Co. Inc. – Key news
o Exhibit 124: Bausch Health Co. Inc. – Key offerings
o Exhibit 125: Bausch Health Co. Inc. – Segment focus
o 12.7 Breckenridge Pharmaceutical Inc.
o Exhibit 126: Breckenridge Pharmaceutical Inc. – Overview
o Exhibit 127: Breckenridge Pharmaceutical Inc. – Product / Service
o Exhibit 128: Breckenridge Pharmaceutical Inc. – Key offerings
o 12.8 Dr Reddys Laboratories Ltd.
o Exhibit 129: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 130: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 131: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 132: Dr Reddys Laboratories Ltd. – Segment focus
o 12.9 Endo International Plc
o Exhibit 133: Endo International Plc – Overview
o Exhibit 134: Endo International Plc – Business segments
o Exhibit 135: Endo International Plc – Key news
o Exhibit 136: Endo International Plc – Key offerings
o Exhibit 137: Endo International Plc – Segment focus
o 12.10 Lupin Ltd.
o Exhibit 138: Lupin Ltd. – Overview
o Exhibit 139: Lupin Ltd. – Product / Service
o Exhibit 140: Lupin Ltd. – Key news
o Exhibit 141: Lupin Ltd. – Key offerings
o 12.11 Merck and Co. Inc.
o Exhibit 142: Merck and Co. Inc. – Overview
o Exhibit 143: Merck and Co. Inc. – Business segments
o Exhibit 144: Merck and Co. Inc. – Key news
o Exhibit 145: Merck and Co. Inc. – Key offerings
o Exhibit 146: Merck and Co. Inc. – Segment focus
o 12.12 Navinta LLC
o Exhibit 147: Navinta LLC – Overview
o Exhibit 148: Navinta LLC – Product / Service
o Exhibit 149: Navinta LLC – Key offerings
o 12.13 Panacea Biotec Ltd.
o Exhibit 150: Panacea Biotec Ltd. – Overview
o Exhibit 151: Panacea Biotec Ltd. – Product / Service
o Exhibit 152: Panacea Biotec Ltd. – Key offerings
o 12.14 Recordati S.p.A
o Exhibit 153: Recordati S.p.A – Overview
o Exhibit 154: Recordati S.p.A – Business segments
o Exhibit 155: Recordati S.p.A – Key offerings
o Exhibit 156: Recordati S.p.A – Segment focus
o 12.15 Taj Pharmaceutical Ltd.
o Exhibit 157: Taj Pharmaceutical Ltd. – Overview
o Exhibit 158: Taj Pharmaceutical Ltd. – Product / Service
o Exhibit 159: Taj Pharmaceutical Ltd. – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Tsumura and Co.
o Exhibit 165: Tsumura and Co. – Overview
o Exhibit 166: Tsumura and Co. – Product / Service
o Exhibit 167: Tsumura and Co. – Key offerings
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global wilsons disease drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Chelators – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Chelators – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Chelators – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Chelators – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Minerals – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Minerals – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Minerals – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Minerals – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Data Table on Market opportunity by Product ($ million)
Exhibits44: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Retail pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Retail pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Hospital pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Hospital pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online pharmacies – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online pharmacies – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: ANI Pharmaceuticals Inc. – Overview
Exhibits112: ANI Pharmaceuticals Inc. – Product / Service
Exhibits113: ANI Pharmaceuticals Inc. – Key offerings
Exhibits114: Apotex Inc. – Overview
Exhibits115: Apotex Inc. – Product / Service
Exhibits116: Apotex Inc. – Key offerings
Exhibits117: AstraZeneca Plc – Overview
Exhibits118: AstraZeneca Plc – Product / Service
Exhibits119: AstraZeneca Plc – Key news
Exhibits120: AstraZeneca Plc – Key offerings
Exhibits121: Bausch Health Co. Inc. – Overview
Exhibits122: Bausch Health Co. Inc. – Business segments
Exhibits123: Bausch Health Co. Inc. – Key news
Exhibits124: Bausch Health Co. Inc. – Key offerings
Exhibits125: Bausch Health Co. Inc. – Segment focus
Exhibits126: Breckenridge Pharmaceutical Inc. – Overview
Exhibits127: Breckenridge Pharmaceutical Inc. – Product / Service
Exhibits128: Breckenridge Pharmaceutical Inc. – Key offerings
Exhibits129: Dr Reddys Laboratories Ltd. – Overview
Exhibits130: Dr Reddys Laboratories Ltd. – Business segments
Exhibits131: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits132: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits133: Endo International Plc – Overview
Exhibits134: Endo International Plc – Business segments
Exhibits135: Endo International Plc – Key news
Exhibits136: Endo International Plc – Key offerings
Exhibits137: Endo International Plc – Segment focus
Exhibits138: Lupin Ltd. – Overview
Exhibits139: Lupin Ltd. – Product / Service
Exhibits140: Lupin Ltd. – Key news
Exhibits141: Lupin Ltd. – Key offerings
Exhibits142: Merck and Co. Inc. – Overview
Exhibits143: Merck and Co. Inc. – Business segments
Exhibits144: Merck and Co. Inc. – Key news
Exhibits145: Merck and Co. Inc. – Key offerings
Exhibits146: Merck and Co. Inc. – Segment focus
Exhibits147: Navinta LLC – Overview
Exhibits148: Navinta LLC – Product / Service
Exhibits149: Navinta LLC – Key offerings
Exhibits150: Panacea Biotec Ltd. – Overview
Exhibits151: Panacea Biotec Ltd. – Product / Service
Exhibits152: Panacea Biotec Ltd. – Key offerings
Exhibits153: Recordati S.p.A – Overview
Exhibits154: Recordati S.p.A – Business segments
Exhibits155: Recordati S.p.A – Key offerings
Exhibits156: Recordati S.p.A – Segment focus
Exhibits157: Taj Pharmaceutical Ltd. – Overview
Exhibits158: Taj Pharmaceutical Ltd. – Product / Service
Exhibits159: Taj Pharmaceutical Ltd. – Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits165: Tsumura and Co. – Overview
Exhibits166: Tsumura and Co. – Product / Service
Exhibits167: Tsumura and Co. – Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

※본 조사보고서 [세계의 윌슨병 치료제 시장 2023-2027] (코드 : IRTNTR75840-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 윌슨병 치료제 시장 2023-2027] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 요도 확장기 시장 (2023~2027) : 유압식 요도 확장기, 기타
IRTNTR72741-23 / Technavio / 2022년 12월 / Technavio사의 본 연구 보고서는 세계의 요도 확장기 시장 규모가 2023년과 2027년 사이에 98.45백만 달러에 도달하며, 예측 기간 중 연평균 성장률은 5.98%가 될 것으로 예상하고 있습니다. 본 보고서는 세계의 요도 확장기...Global Urethral Dilator Market 2023-2027Technavio has been monitoring the urethral dilator market and is forecast to grow by $98.45 mn during 2022-2027, accelerating at a CAGR of 5.98% during the forecast period. Our report on the urethral dilator market provides a holistic analysis, market size and forecast, trends, growth drivers,...

세계의 의치 시장 (2023~2027) : 부분 틀니, 전체 틀니
IRTNTR45461-23 / Technavio / 2022년 12월 / Technavio사(테크나비오)는 세계의 의치 시장 규모가 2022년부터 2027년까지 연평균 6.85% 성장하여, 991.6백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 의치 시장에 대해 다방면으로 조사 및 분석하여, 개요, 시장 현황,...Global Dentures Market 2023-2027Technavio has been monitoring the dentures market and is forecast to grow by $991.6 mn during 2022-2027, accelerating at a CAGR of 6.85% during the forecast period. Our report on the dentures market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as...

세계의 듀셴형 근이영양증 (DMD) 치료제 시장 2023-2027
IRTNTR71927-23 / Technavio / 2023년 7월 / 글로벌 듀셴형 근이영양증 (DMD) 치료제 시장 2023-2027 듀셴형 근이영양증 (DMD) 치료제 시장은 2022년부터 2027년까지 23억 9,767만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 21.2%의 CAGR을 기록할 것으로 전망된다. 이...1. 개요 2. 세계의 듀셴형 근이영양증 (DMD) 치료제 시장 현황 3. 세계의 듀셴형 근이영양증 (DMD) 치료제 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 유통 채널별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석...

세계의 요소 회로 이상증 치료 시장 2023-2027
IRTNTR75899-23 / Technavio / 2023년 7월 / 글로벌 요소 회로 이상증 치료 시장 2023-2027 요소 회로 이상증 치료 시장은 2022년부터 2027년까지 2억 3,550만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 3.57%의 CAGR을 기록할 것으로 예상됩니다. 이...1. 개요 2. 세계의 요소 회로 이상증 치료 시장 현황 3. 세계의 요소 회로 이상증 치료 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 치료법별 시장 분석 7. 투여 경로별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석...

세계의 IVF 소모품 시장 2023-2027
IRTNTR75941-23 / Technavio / 2023년 7월 / 글로벌 IVF 소모품 시장 2023-2027 IVF 소모품 시장은 2022년부터 2027년까지 2억 4853만 달러로 성장하며, 예측 기간 동안 7.66%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 IVF 소모품 시장에 대한 전반적인 분석,...1. 개요 2. 세계의 IVF 소모품 시장 현황 3. 세계의 IVF 소모품 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 최종 용도별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!